Results 81 to 90 of about 33,865 (284)

Supplemental peri-operative intravenous crystalloids for postoperative nausea and vomiting: an abridged Cochrane systematic review. [PDF]

, 2020
We conducted a Cochrane systematic review on the effectiveness of supplemental intravenous crystalloid administration in preventing postoperative nausea and vomiting.
Bird, SJ, George, RB, Habib, AS, Jewer, JK, Parker, R, Wong, MJ   +5 more
core  

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double‐blind, randomized controlled trial

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This study tested the effectiveness of rimegepant for migraine prevention in Japan. Results showed that rimegepant was more effective than placebo in reducing monthly migraine days, with very few adverse effects. These results support the previous findings from a clinical study conducted in the United States and broaden them to ...
Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima   +11 more
wiley   +1 more source

PROPHYLACTIC ANTIEMETIC THERAPY WITH ONDANSETRON, DEXAMETHASONE AND COMBINED ONDANSETRON AND DEXAMETHASONE IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANAESTHESIA (GA)

Journal of University Medical & Dental College, 2017
: OBJECTIVE: The aim of this study was to find a better prophylaxis against postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy. STUDY DESIGN: A randomized control study was carried out for comparison.
Nadia Bano, Nazim Hayat, A.G Rehan
doaj  

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting

SAGE Open Medicine, 2018
Objectives: To evaluate the treatment pattern of antiemetic agents used for chemotherapy-induced nausea and vomiting in a tertiary hospital in Saudi Arabia. Methods: Over a period of 7 weeks, all new chemotherapy order sheets were collected and evaluated
Abdulrahman Alamri, Yousef A Alawlah, Yanru Qiao, Junling Wang   +3 more
doaj   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma. [PDF]

Clin Endocrinol (Oxf)
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Majumder M, Chiang C, Kong G, Michael M, Sachithanandan N, Boehm E.   +5 more
europepmc   +2 more sources

Clinical outcomes of patients seen by psychiatrists in a multidisciplinary clinic for disorders of gut‐brain interaction

Internal Medicine Journal, EarlyView.
Abstract Background Patients with disorders of gut‐brain interaction (DGBIs) presenting to specialist care have a high prevalence of psychiatric morbidity. Psychiatrists can provide effective treatments for these disorders; however, care is rarely delivered in an integrated manner. Aims This study aimed to characterise patients seen by psychiatrists in
Evangelia Dendrinos, Hannah Kim, Daniel Hubik, Jessica Green, Linda Yang, Annalise Stanley, Michael Salzberg, Michael A Kamm, Chamara Basnayake   +8 more
wiley   +1 more source

The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review

European Psychiatry
Background Medication-induced dystonia (MID) is a movement disorder (MD), characterized by involuntary sustained or intermittent muscle contractions, causing abnormal, often repetitive, movements, postures, or both.
Kirsten Catthoor, Johan Detraux, Marc De Hert   +2 more
doaj   +1 more source

Perspectives and Requirements of Patients with Prostate Cancer on Mobile Health Interventions During Androgen Deprivation Therapy: A Descriptive Qualitative Study

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim To explore the perceptions of patients with prostate cancer undergoing androgen deprivation therapy towards mobile health interventions. Design The study employed a qualitative descriptive design. Methods Seventeen participants were recruited from tertiary care hospitals from November 2022 to June 2023. The collected data were subsequently
Hongfan Yin, Chen Pan, Jia Gu, Yan Yang
wiley   +1 more source

Incidence and Characteristics of Hospital‐Acquired Pressure Injuries in Acute Palliative Care Patients: A Four‐Year Analysis

Journal of Clinical Nursing, EarlyView.
ABSTRACT Aim To describe the cumulative incidence and characteristics of hospital‐acquired pressure injury in acute palliative patients. Design Secondary data analysis of hospital‐acquired pressure injuries during 2019–2022. Methods The setting was a palliative care unit at a tertiary hospital in Queensland, Australia, including adult (≥ 18 years ...
Saroeun Ven, Michael Steele, Adam Burston, Paul Fulbrook, Josephine Lovegrove, Sandra Miles, Susan Prince   +6 more
wiley   +1 more source